Effect of adjuvant therapy on the risk of recurrence in early-stage leiomyosarcoma: A meta-analysis

•This meta-analysis included 747 early uLMS cases from 12 studies.•Neither AC nor AR reduced recurrence in surgically treated patients with early uLMS.•This was consistently observed in the subgroup analysis of gemcitabine/docetaxel regimen.